Saffron has moved from the spice rack into pediatric mood and ADHD trials.

- Clinical trials on saffron for children are small and short (50-60 kids, 6-8 weeks) but show promising results for ADHD symptoms and adolescent mood
- The 2019 Baziar trial found saffron 20-30 mg/day produced comparable ADHD improvement to methylphenidate over 6 weeks in children aged 6-17
- Saffron has shown a mild side effect profile in pediatric trials, but long-term safety data does not exist
- Do not give saffron supplements to children under age 6; ages 6 and up require physician supervision
- Always choose a standardized extract (affron or similar) with third-party testing certification, not bulk saffron powder or unverified products
- Saffron is not a substitute for therapy or evidence-based treatment; address sleep, exercise, and diet foundations first
Why Parents Are Asking About Saffron for Kids
I’ll be honest: five years ago, if a parent asked me about giving saffron to their child for ADHD or anxiety, I would have raised an eyebrow. Today, I take the question seriously.
Here’s the thing. Saffron has traveled from the spice rack to peer-reviewed clinical journals at a pace that’s hard to ignore. Over 15 years, researchers have accumulated real evidence in adults for mild-to-moderate depression and anxiety. A 2020 meta-analysis pooled data from 23 randomized trials and found consistent antidepressant effects at doses of 30 mg/day. That track record in adults opened the door for researchers to ask whether the same might apply to children.
Now the trials are happening. Small but real clinical studies are testing saffron for children’s mental health, specifically ADHD, anxiety, and depressive symptoms in adolescents. The results are generating genuine scientific interest, not just wellness-blog excitement.
I understand the appeal for parents. A non-pharmaceutical option, derived from a food, with a decent adult safety profile. When your child is struggling and you’re watching a waiting list for a child psychiatrist stretch to six months, that appeal isn’t irrational.
But the safety bar for kids is categorically higher than for adults. Developing brains, smaller body mass, faster metabolism, and the long-term unknowns all matter. So let me walk you through what the research on saffron for children actually says, the doses studied, the side effects reported, and where the honest gaps are.
What the Research Says: Saffron for Children's Mental Health
The study that put pediatric saffron research on the map came from Baziar and colleagues in 2019. Published in the Journal of Child and Adolescent Psychopharmacology, it randomized 54 children aged 6 to 17 with diagnosed ADHD to receive either saffron extract (20-30 mg/day) or methylphenidate for six weeks. Both groups showed comparable improvement on parent- and teacher-rated ADHD symptom scales. That’s a striking finding, though I’ll come back to the caveats in a moment.
The 2022 Lopresti adolescent trial looked at a different population. Adolescents with self-reported anxiety and depressive symptoms received a proprietary saffron extract called affron at 14 mg twice daily for eight weeks. Significant improvements in mood scores were observed versus placebo. This wasn’t a clinical ADHD population, but it broadens the picture for saffron’s potential role in adolescent mental health.
So what’s the mechanism? Crocin and safranal, the two main bioactive compounds in saffron, appear to modulate serotonin reuptake and may influence dopamine signaling. Think of it as a gentler, more diffuse nudge to the same neurotransmitter systems that pharmaceutical ADHD medications target more forcefully. Animal models also show antioxidant and anti-inflammatory effects in brain tissue, though extrapolating from rodents to a 10-year-old is always a leap worth flagging.
Here’s where I put on the brakes, though. Both trials involved 50 to 60 participants. Both ran for six to eight weeks. Both were single-center. There are no large, multi-site randomized controlled trials in pediatric populations. The Cochrane Collaboration, which sets the standard for evidence-based review, has not endorsed saffron for pediatric use in any condition. A 2023 systematic review in Nutrients acknowledged the promising signals but explicitly called for longer-duration studies with more rigorous methodology before clinical recommendations could be made.
Bottom line: the evidence is genuinely promising. It’s also genuinely preliminary.

Is Saffron Safe for Kids?
Adults have a clean safety record with saffron at 30 mg/day or less. Across dozens of trials, the adverse event profile is minor: occasional GI upset, mild headache, appetite changes. Serious adverse events are rare to nonexistent at those doses.
The pediatric trial data mirrors that profile. No serious adverse events were reported in the Baziar 2019 trial or the Lopresti 2022 trial. The side effects kids experienced (appetite changes, some GI discomfort) were mild and similar in frequency to the comparison groups.
That said, I don’t think “no serious events in 60 kids over six weeks” is the same as a confirmed safety green light.
Children metabolize compounds differently than adults. Their brains are still developing, particularly the prefrontal cortex and dopamine-reward circuitry that runs deep into early adulthood. We simply don’t have long-term pediatric data on saffron supplementation, and the honest answer is we don’t know what sustained serotonin and dopamine modulation looks like in a developing brain over months or years.
There are also real practical safety concerns that go beyond the clinical trials. Saffron extracts are sold as dietary supplements, not regulated pharmaceuticals. Potency varies significantly between brands. A capsule labeled “30 mg saffron extract” from one brand may have an entirely different bioactive compound profile than one from another (it’s not standardized industry-wide unless the manufacturer specifically standardizes it). That variability matters more for a child than an adult.
Drug interactions are worth flagging specifically. Saffron has documented mild antiplatelet effects. If your child is on blood thinners or has a bleeding disorder, this is a real conversation to have with a physician before starting. And for children with any history of bipolar tendencies or manic episodes, starting any supplement with mood-active properties without psychiatric input is not a path I’d support.
Age Guidelines: When (and When Not) to Consider Saffron
Let me be direct here, because I see a lot of vague hedging on this topic online.
Under age 6: don’t do it. There is no published pediatric trial in this age group. Zero data means zero basis for a dosing recommendation. The answer is no.
Ages 6 to 11: physician supervision only. The Baziar 2019 trial included children as young as 6, which gives us some basis for discussion, but the lowest studied dose was 20 mg/day of standardized extract. This isn’t something to eyeball with a kitchen scale or guess at from adult dosing. If your child’s pediatrician or child psychiatrist isn’t part of this decision, you’re operating without a safety net.
Ages 12 and up: the evidence is slightly more developed. The Lopresti 2022 trial used 14 mg twice daily (28 mg total) in adolescents, and the Baziar trial extended to age 17 at 20 to 30 mg/day. Still, physician oversight applies.
One population that needs a hard stop: pregnant or breastfeeding adolescents. High-dose saffron has documented uterotonic properties, meaning it can stimulate uterine contractions. This is historically why it was used as an abortifacient in traditional medicine. Even at supplemental doses, this is not a risk worth taking.
The bigger picture before any supplement conversation: sleep quality, screen time limits, physical activity, and diet quality are the foundations. I’ve seen kids’ attention and mood improve substantially with targeted sleep hygiene alone. Supplements don’t replace those foundations.
Saffron Dosage for Children and How to Choose a Quality Product

Saffron dosage for children in published trials has consistently fallen in the 20 to 30 mg/day range for standardized extract. The Baziar 2019 trial used 20 to 30 mg/day depending on weight. Lopresti 2022 used 14 mg twice daily. Both used standardized proprietary extracts, not bulk saffron powder.
That standardization piece matters enormously. The two extracts with the most pediatric and adult research behind them are affron (standardized to 3.5% lepticrosalide) and Saffr’Activ (standardized to specific crocin and safranal levels). If you’re going to take this seriously, look for one of those, or at minimum a product that specifies the percentage of crocin and/or safranal per dose. A generic “saffron 100 mg” capsule with no standardization information tells you very little about actual bioactive content.
What to avoid is straightforward: products that combine saffron with 10 other unrelated herbs (because you lose the ability to attribute effects or side effects to any single ingredient), very high doses marketed for adults, and anything without third-party testing documentation. Look for USP, NSF International, or Informed Sport certification, or a published Certificate of Analysis (COA) from an independent lab.
Timing: most trials used morning dosing. Some used split doses (morning and afternoon). Evening dosing hasn’t been widely studied and I’d stick with what the trials used.
On onset: don’t expect results in two weeks. Improvements in the trials typically emerged after four to eight weeks of consistent daily use. If you reach 12 weeks with no observable change in the symptoms you were targeting, that’s the signal to stop and reassess with your doctor rather than double the dose.
What to Talk to Your Doctor About First
Bring the supplement bottle to the appointment. I mean that literally. Show the dose, the extract type, the certifications, the inactive ingredients. Your pediatrician can’t evaluate what they can’t see.
The conversation should cover: current medications and potential interactions (especially anything affecting bleeding, seizure threshold, or mood), the severity and functional impact of your child’s ADHD or anxiety, and whether a formal diagnostic workup has happened if it hasn’t already. Saffron is not a substitute for an accurate diagnosis.
Published in Complementary Therapies in Medicine in 2022, a review of supplement-drug interactions in pediatric populations specifically flagged saffron’s serotonergic activity as worth discussing when children are already on SSRIs or stimulant medications. Not necessarily a contraindication, but a conversation.
Plan a follow-up at six to eight weeks. Track symptoms with whatever validated scale your pediatrician uses (Vanderbilt for ADHD, for example) so you have objective data, not just impressions.
Red flags to stop immediately: skin rash, persistent GI upset beyond the first week, unusual irritability, or any mood change that feels out of character. Those symptoms mean stop the supplement and call your doctor, not “wait and see.”
Saffron is not a substitute for cognitive behavioral therapy, behavioral parent training, or evidence-based treatment when those are clinically indicated. I want to be clear on that. For some families, a supplement may be a reasonable part of a broader support plan. For others, it’s a detour from the care that would actually help.

Frequently Asked Questions
Is saffron safe for kids? Based on current pediatric trial data, saffron at 20 to 30 mg/day of standardized extract appears to have a mild side effect profile in children aged 6 and up. No serious adverse events have been reported in published trials. That said, long-term safety data doesn’t exist, and physician supervision is essential before starting.
What age can children take saffron supplements? The youngest children included in clinical trials were age 6. There’s no data below that age, so supplementing children under 6 isn’t supported. Ages 6 to 11 require physician supervision. Ages 12 and up have slightly more trial data, but still need medical oversight.
Does saffron really work for ADHD in children? The Baziar 2019 trial found comparable ADHD symptom improvement between saffron and methylphenidate over six weeks in 54 children. That’s interesting. It’s also one small single-center trial. The evidence is promising, not conclusive. I wouldn’t describe saffron as a proven ADHD treatment, but I also wouldn’t dismiss the signal.
How much saffron should a child take? Studied saffron dosage for children ranges from 20 to 30 mg/day of standardized extract, depending on age and study design. Always use a standardized extract (not bulk spice), and always use a dose determined with your child’s physician based on weight and condition.
How long does it take saffron to work in kids? Consistent with adult trials, the pediatric studies observed improvements at four to eight weeks. Don’t expect changes in the first two weeks. If there’s no observable benefit by 12 weeks, stop and reassess.
Can saffron interact with ADHD medications? Possibly. Saffron has mild serotonergic activity, which is relevant if your child is on any medication affecting serotonin. It also has mild antiplatelet effects. These interactions aren’t necessarily prohibitive, but they require a conversation with your child’s prescribing physician before combining.
Frequently Asked Questions
Based on current pediatric trial data, saffron at 20 to 30 mg/day of standardized extract appears to have a mild side effect profile in children aged 6 and up. No serious adverse events have been reported in published trials. That said, long-term safety data doesn't exist, and physician supervision is essential before starting.
The youngest children included in clinical trials were age 6. There's no data below that age, so supplementing children under 6 isn't supported. Ages 6 to 11 require physician supervision. Ages 12 and up have slightly more trial data, but still need medical oversight.
The Baziar 2019 trial found comparable ADHD symptom improvement between saffron and methylphenidate over six weeks in 54 children. That's interesting. It's also one small single-center trial. The evidence is promising, not conclusive. I wouldn't describe saffron as a proven ADHD treatment, but I also wouldn't dismiss the signal.
Studied saffron dosage for children ranges from 20 to 30 mg/day of standardized extract, depending on age and study design. Always use a standardized extract (not bulk spice), and always use a dose determined with your child's physician based on weight and condition.
Consistent with adult trials, the pediatric studies observed improvements at four to eight weeks. Don't expect changes in the first two weeks. If there's no observable benefit by 12 weeks, stop and reassess.
Clinical trials on saffron for children are small and short (50-60 kids, 6-8 weeks) but show promising results for ADHD symptoms and adolescent mood The 2019 Baziar trial found saffron 20-30 mg/day produced comparable ADHD improvement to methylphenidate over 6 weeks in children aged 6-17 Saffron has shown a mild side effect profile in pediatric trials, but long-term safety data does not exist